| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteonectin | 43 | 2020 | 69 | 12.080 |
Why?
|
| Myocardium | 27 | 2022 | 1204 | 6.650 |
Why?
|
| Extracellular Matrix | 29 | 2023 | 493 | 4.820 |
Why?
|
| Collagen | 22 | 2023 | 636 | 4.640 |
Why?
|
| Fibroblasts | 26 | 2023 | 902 | 3.610 |
Why?
|
| Collagen Type I | 11 | 2017 | 175 | 2.630 |
Why?
|
| Periodontal Ligament | 5 | 2019 | 16 | 2.600 |
Why?
|
| Fibrosis | 13 | 2022 | 371 | 2.150 |
Why?
|
| Procollagen | 7 | 2013 | 31 | 2.110 |
Why?
|
| Fibrillar Collagens | 8 | 2020 | 49 | 2.020 |
Why?
|
| Aging | 9 | 2018 | 911 | 1.770 |
Why?
|
| Macrophages | 6 | 2021 | 647 | 1.470 |
Why?
|
| Animals | 66 | 2023 | 20877 | 1.440 |
Why?
|
| Cardiomegaly | 4 | 2020 | 213 | 1.440 |
Why?
|
| Mice | 46 | 2023 | 8472 | 1.350 |
Why?
|
| Transglutaminases | 3 | 2019 | 67 | 1.340 |
Why?
|
| Mice, Inbred C57BL | 24 | 2022 | 2790 | 1.330 |
Why?
|
| Heart Failure | 7 | 2023 | 1179 | 1.150 |
Why?
|
| Mice, Knockout | 22 | 2019 | 1692 | 1.100 |
Why?
|
| Extracellular Matrix Proteins | 8 | 2016 | 144 | 1.090 |
Why?
|
| Periodontitis | 2 | 2019 | 47 | 1.070 |
Why?
|
| Heart Ventricles | 5 | 2022 | 738 | 1.060 |
Why?
|
| Ventricular Remodeling | 5 | 2022 | 318 | 0.950 |
Why?
|
| Recombinant Proteins | 6 | 2017 | 742 | 0.880 |
Why?
|
| Ventricular Function, Left | 6 | 2022 | 481 | 0.870 |
Why?
|
| Pulmonary Fibrosis | 2 | 2020 | 157 | 0.830 |
Why?
|
| Cell Culture Techniques | 4 | 2017 | 189 | 0.800 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 807 | 0.800 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 244 | 0.780 |
Why?
|
| Wound Healing | 5 | 2015 | 260 | 0.780 |
Why?
|
| Cytokines | 3 | 2020 | 866 | 0.760 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2020 | 5 | 0.750 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2022 | 140 | 0.740 |
Why?
|
| Cells, Cultured | 19 | 2023 | 2673 | 0.740 |
Why?
|
| Sex Characteristics | 1 | 2022 | 295 | 0.730 |
Why?
|
| Gene Expression Regulation | 10 | 2020 | 1293 | 0.730 |
Why?
|
| Blood Pressure | 4 | 2020 | 1447 | 0.710 |
Why?
|
| Bone and Bones | 2 | 2020 | 145 | 0.700 |
Why?
|
| Biomarkers | 6 | 2022 | 1593 | 0.680 |
Why?
|
| Cell Differentiation | 11 | 2020 | 1034 | 0.680 |
Why?
|
| Lung | 2 | 2020 | 849 | 0.660 |
Why?
|
| Heart Diseases | 1 | 2020 | 276 | 0.640 |
Why?
|
| Myocarditis | 2 | 2015 | 49 | 0.640 |
Why?
|
| Iron Overload | 1 | 2018 | 28 | 0.640 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2018 | 15 | 0.640 |
Why?
|
| Inflammation | 4 | 2021 | 1030 | 0.610 |
Why?
|
| Dermis | 2 | 2010 | 29 | 0.610 |
Why?
|
| School Teachers | 1 | 2016 | 3 | 0.590 |
Why?
|
| Global Warming | 1 | 2016 | 4 | 0.590 |
Why?
|
| Climate Change | 1 | 2016 | 17 | 0.580 |
Why?
|
| ADAMTS1 Protein | 1 | 2016 | 9 | 0.570 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 595 | 0.560 |
Why?
|
| Alveolar Bone Loss | 2 | 2019 | 40 | 0.560 |
Why?
|
| Calcification, Physiologic | 1 | 2016 | 31 | 0.560 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 277 | 0.560 |
Why?
|
| Diastole | 4 | 2020 | 161 | 0.550 |
Why?
|
| Cell Proliferation | 8 | 2022 | 1173 | 0.550 |
Why?
|
| Macrophages, Peritoneal | 1 | 2015 | 67 | 0.520 |
Why?
|
| Students | 1 | 2016 | 233 | 0.490 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 442 | 0.470 |
Why?
|
| Hypertension | 3 | 2022 | 1531 | 0.460 |
Why?
|
| Gene Expression | 1 | 2015 | 770 | 0.450 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2012 | 21 | 0.440 |
Why?
|
| Glycoproteins | 2 | 2012 | 238 | 0.440 |
Why?
|
| Male | 24 | 2022 | 37281 | 0.430 |
Why?
|
| Collagen Type V | 1 | 2011 | 1 | 0.410 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2015 | 284 | 0.400 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 117 | 0.390 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 1 | 2010 | 18 | 0.390 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 146 | 0.390 |
Why?
|
| Phosphopeptides | 1 | 2010 | 8 | 0.380 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 2550 | 0.380 |
Why?
|
| Hernia, Abdominal | 1 | 2010 | 7 | 0.380 |
Why?
|
| Age Factors | 4 | 2020 | 1860 | 0.380 |
Why?
|
| Heart Failure, Diastolic | 1 | 2009 | 14 | 0.360 |
Why?
|
| Osteoblasts | 3 | 2020 | 99 | 0.360 |
Why?
|
| Cell Membrane | 1 | 2011 | 523 | 0.360 |
Why?
|
| Female | 14 | 2022 | 38015 | 0.350 |
Why?
|
| Baculoviridae | 2 | 2017 | 14 | 0.350 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 1032 | 0.350 |
Why?
|
| Heart | 4 | 2018 | 850 | 0.340 |
Why?
|
| RNA, Messenger | 7 | 2020 | 1663 | 0.340 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 455 | 0.330 |
Why?
|
| Immunohistochemistry | 10 | 2017 | 1174 | 0.330 |
Why?
|
| Humans | 25 | 2022 | 68525 | 0.310 |
Why?
|
| Microfibrils | 1 | 2007 | 2 | 0.310 |
Why?
|
| Skin Physiological Phenomena | 1 | 2007 | 13 | 0.310 |
Why?
|
| Skin | 5 | 2015 | 451 | 0.310 |
Why?
|
| Osteoclasts | 2 | 2020 | 132 | 0.300 |
Why?
|
| X-Ray Microtomography | 2 | 2019 | 50 | 0.280 |
Why?
|
| Signal Transduction | 6 | 2020 | 2688 | 0.270 |
Why?
|
| Phenotype | 5 | 2015 | 946 | 0.270 |
Why?
|
| Neovascularization, Physiologic | 4 | 2011 | 164 | 0.260 |
Why?
|
| Exons | 2 | 2017 | 122 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 5 | 2012 | 384 | 0.230 |
Why?
|
| Hydroxyproline | 3 | 2010 | 33 | 0.230 |
Why?
|
| Tissue Engineering | 2 | 2023 | 212 | 0.230 |
Why?
|
| Body Weight | 2 | 2010 | 554 | 0.210 |
Why?
|
| Mice, Inbred Strains | 4 | 2010 | 181 | 0.210 |
Why?
|
| Genotype | 2 | 2017 | 785 | 0.210 |
Why?
|
| Solubility | 3 | 2015 | 134 | 0.210 |
Why?
|
| Spodoptera | 2 | 2017 | 21 | 0.210 |
Why?
|
| Adipose Tissue | 1 | 2003 | 221 | 0.210 |
Why?
|
| Ventricular Pressure | 1 | 2022 | 82 | 0.210 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 133 | 0.200 |
Why?
|
| Integrins | 3 | 2014 | 115 | 0.200 |
Why?
|
| Bone Marrow Cells | 2 | 2020 | 217 | 0.190 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 45 | 0.190 |
Why?
|
| Neoplasms | 2 | 2012 | 1660 | 0.190 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2020 | 14 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1548 | 0.190 |
Why?
|
| Tensile Strength | 2 | 2015 | 90 | 0.190 |
Why?
|
| Mice, Mutant Strains | 3 | 2015 | 166 | 0.190 |
Why?
|
| Cell Count | 2 | 2010 | 248 | 0.190 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 149 | 0.180 |
Why?
|
| Cell Adhesion | 4 | 2012 | 324 | 0.180 |
Why?
|
| Biotin | 1 | 2019 | 28 | 0.180 |
Why?
|
| Cell Communication | 1 | 2020 | 116 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 282 | 0.180 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 183 | 0.180 |
Why?
|
| Cats | 2 | 2012 | 292 | 0.170 |
Why?
|
| Antigens, CD | 1 | 2020 | 230 | 0.170 |
Why?
|
| Mechanical Phenomena | 2 | 2017 | 21 | 0.170 |
Why?
|
| Rats | 6 | 2022 | 5300 | 0.170 |
Why?
|
| Integrin beta1 | 2 | 1996 | 48 | 0.170 |
Why?
|
| Amines | 1 | 2019 | 98 | 0.170 |
Why?
|
| Random Allocation | 1 | 2019 | 442 | 0.160 |
Why?
|
| Mesoderm | 1 | 1999 | 231 | 0.160 |
Why?
|
| Stroke Volume | 5 | 2022 | 586 | 0.160 |
Why?
|
| Sf9 Cells | 1 | 2017 | 3 | 0.160 |
Why?
|
| Culture Media, Conditioned | 1 | 2017 | 78 | 0.160 |
Why?
|
| Macrophage Activation | 2 | 2015 | 75 | 0.160 |
Why?
|
| Pressure | 2 | 2015 | 252 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 2 | 2012 | 332 | 0.150 |
Why?
|
| Stem Cells | 2 | 2016 | 248 | 0.150 |
Why?
|
| Collagen Type II | 1 | 2017 | 13 | 0.150 |
Why?
|
| Chondrogenesis | 1 | 2017 | 15 | 0.150 |
Why?
|
| Retina | 2 | 1996 | 252 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2017 | 311 | 0.150 |
Why?
|
| Genetic Pleiotropy | 1 | 2016 | 10 | 0.150 |
Why?
|
| Aorta | 2 | 2015 | 316 | 0.150 |
Why?
|
| Cell Movement | 7 | 2015 | 630 | 0.140 |
Why?
|
| Prognosis | 1 | 2022 | 2093 | 0.140 |
Why?
|
| Public Opinion | 1 | 2016 | 32 | 0.140 |
Why?
|
| Scleroderma, Systemic | 1 | 2020 | 446 | 0.140 |
Why?
|
| Molecular Weight | 4 | 2015 | 358 | 0.140 |
Why?
|
| Tendons | 1 | 2016 | 45 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 167 | 0.140 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2016 | 8 | 0.140 |
Why?
|
| North Carolina | 1 | 2016 | 224 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2018 | 193 | 0.140 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 111 | 0.140 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 27 | 0.140 |
Why?
|
| Dasatinib | 1 | 2015 | 17 | 0.140 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 48 | 0.140 |
Why?
|
| Chemokine CX3CL1 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Receptors, CCR2 | 1 | 2015 | 9 | 0.130 |
Why?
|
| Keratan Sulfate | 1 | 2015 | 12 | 0.130 |
Why?
|
| Receptors, CXCR3 | 1 | 2015 | 16 | 0.130 |
Why?
|
| Chemotaxis | 1 | 2015 | 38 | 0.130 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 23 | 0.130 |
Why?
|
| Adipogenesis | 2 | 2016 | 17 | 0.130 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 36 | 0.130 |
Why?
|
| Cell Division | 3 | 2002 | 541 | 0.130 |
Why?
|
| Connectin | 1 | 2015 | 14 | 0.130 |
Why?
|
| Osteoporosis | 1 | 2016 | 88 | 0.130 |
Why?
|
| Cicatrix | 1 | 2015 | 60 | 0.130 |
Why?
|
| Acetylglucosamine | 1 | 2015 | 46 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 209 | 0.130 |
Why?
|
| Collagen Type III | 1 | 2014 | 21 | 0.120 |
Why?
|
| Elasticity | 2 | 2015 | 103 | 0.120 |
Why?
|
| Collagen Type IV | 1 | 2014 | 28 | 0.120 |
Why?
|
| Homeostasis | 2 | 2018 | 291 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2016 | 682 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2015 | 246 | 0.120 |
Why?
|
| Myofibroblasts | 1 | 2014 | 60 | 0.120 |
Why?
|
| Temporomandibular Joint Disc | 1 | 2013 | 10 | 0.110 |
Why?
|
| Gene Deletion | 3 | 2010 | 235 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 331 | 0.110 |
Why?
|
| Integrin beta3 | 1 | 2012 | 35 | 0.110 |
Why?
|
| Follistatin | 1 | 2012 | 5 | 0.110 |
Why?
|
| EF Hand Motifs | 1 | 2012 | 6 | 0.110 |
Why?
|
| Losartan | 1 | 2012 | 45 | 0.110 |
Why?
|
| Protein Folding | 1 | 2012 | 82 | 0.100 |
Why?
|
| Collagenases | 1 | 2011 | 34 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2012 | 71 | 0.100 |
Why?
|
| Gingival Diseases | 1 | 2010 | 22 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 216 | 0.100 |
Why?
|
| Aged | 4 | 2022 | 14842 | 0.100 |
Why?
|
| Connective Tissue | 1 | 2010 | 61 | 0.100 |
Why?
|
| Fibronectins | 2 | 2012 | 130 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 44 | 0.100 |
Why?
|
| Mutation | 1 | 2016 | 1213 | 0.090 |
Why?
|
| Maxilla | 1 | 2010 | 63 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2010 | 103 | 0.090 |
Why?
|
| Glomerular Mesangium | 2 | 2000 | 53 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2003 | 312 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 322 | 0.090 |
Why?
|
| Models, Biological | 2 | 2015 | 981 | 0.090 |
Why?
|
| Mortality | 1 | 2010 | 162 | 0.090 |
Why?
|
| Proteome | 1 | 2009 | 87 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2798 | 0.080 |
Why?
|
| Cell Survival | 3 | 2020 | 901 | 0.080 |
Why?
|
| Middle Aged | 3 | 2022 | 21119 | 0.080 |
Why?
|
| Cell Size | 2 | 2015 | 76 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2012 | 954 | 0.080 |
Why?
|
| Proteomics | 1 | 2009 | 246 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2012 | 1329 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 689 | 0.070 |
Why?
|
| Time Factors | 2 | 2012 | 4655 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2004 | 510 | 0.070 |
Why?
|
| Thrombospondins | 1 | 2005 | 5 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2004 | 88 | 0.070 |
Why?
|
| Actins | 1 | 2006 | 249 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 328 | 0.060 |
Why?
|
| Focal Adhesion Kinase 2 | 2 | 2015 | 18 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 2002 | 201 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 114 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2015 | 89 | 0.060 |
Why?
|
| Acetic Acid | 1 | 2003 | 14 | 0.060 |
Why?
|
| Adolescent | 1 | 2016 | 8903 | 0.060 |
Why?
|
| Epididymis | 1 | 2003 | 10 | 0.060 |
Why?
|
| Foreign-Body Reaction | 1 | 2003 | 24 | 0.060 |
Why?
|
| DNA Primers | 1 | 2003 | 302 | 0.060 |
Why?
|
| Obesity | 1 | 2010 | 1074 | 0.060 |
Why?
|
| Bioreactors | 1 | 2023 | 65 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2023 | 208 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2004 | 371 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 579 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2003 | 159 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 710 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2011 | 219 | 0.050 |
Why?
|
| Microcirculation | 1 | 2001 | 77 | 0.050 |
Why?
|
| Bleomycin | 1 | 2020 | 67 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 35 | 0.050 |
Why?
|
| Polyvinyl Alcohol | 3 | 2005 | 8 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 42 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 170 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2020 | 124 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 82 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2000 | 99 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2000 | 136 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2020 | 73 | 0.050 |
Why?
|
| Glycosylation | 1 | 2000 | 185 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2012 | 306 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2001 | 235 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 369 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2000 | 77 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 226 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2015 | 396 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 39 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 330 | 0.040 |
Why?
|
| Chick Embryo | 2 | 1996 | 379 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2011 | 126 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2018 | 108 | 0.040 |
Why?
|
| Cataract | 1 | 1999 | 134 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1999 | 317 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2018 | 144 | 0.040 |
Why?
|
| Monocytes | 1 | 2018 | 210 | 0.040 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1996 | 28 | 0.040 |
Why?
|
| Cell Shape | 1 | 2016 | 37 | 0.040 |
Why?
|
| Receptors, Laminin | 1 | 1996 | 4 | 0.040 |
Why?
|
| Neurites | 1 | 1996 | 18 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 1996 | 72 | 0.030 |
Why?
|
| Laminin | 1 | 1996 | 62 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 929 | 0.030 |
Why?
|
| Receptors, Collagen | 1 | 1995 | 9 | 0.030 |
Why?
|
| Constriction | 1 | 2015 | 37 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 55 | 0.030 |
Why?
|
| Decorin | 1 | 2015 | 8 | 0.030 |
Why?
|
| Lumican | 1 | 2015 | 8 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 186 | 0.030 |
Why?
|
| Nanofibers | 1 | 2015 | 21 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 368 | 0.030 |
Why?
|
| Compliance | 1 | 2015 | 26 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2015 | 88 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 1996 | 199 | 0.030 |
Why?
|
| Fetus | 1 | 2015 | 157 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2015 | 100 | 0.030 |
Why?
|
| Gestational Age | 1 | 1995 | 389 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2015 | 305 | 0.030 |
Why?
|
| Discoidin Domain Receptors | 1 | 2014 | 16 | 0.030 |
Why?
|
| Kidney | 1 | 1999 | 945 | 0.030 |
Why?
|
| Receptors, Mitogen | 1 | 2014 | 23 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2004 | 167 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 791 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 100 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2015 | 249 | 0.030 |
Why?
|
| Fluorescein | 1 | 2013 | 15 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1640 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2013 | 74 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 539 | 0.030 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 15 | 0.030 |
Why?
|
| Diffusion | 1 | 2013 | 90 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 170 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 25 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 507 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 105 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 236 | 0.030 |
Why?
|
| S100 Proteins | 1 | 2012 | 42 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 1199 | 0.030 |
Why?
|
| Integrin alphaV | 1 | 2011 | 3 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 236 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2012 | 95 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1745 | 0.030 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2011 | 7 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2011 | 48 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 223 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2009 | 48 | 0.020 |
Why?
|
| Cattle | 2 | 2004 | 475 | 0.020 |
Why?
|
| Adipocytes | 1 | 2010 | 88 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 320 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2009 | 30 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 131 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 383 | 0.020 |
Why?
|
| Perfusion | 1 | 2009 | 131 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 49 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 159 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2009 | 65 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 1055 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 453 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 498 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1039 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1037 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 1026 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 2083 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 492 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 306 | 0.020 |
Why?
|
| Surgical Sponges | 1 | 2005 | 5 | 0.020 |
Why?
|
| Gels | 1 | 2005 | 55 | 0.020 |
Why?
|
| Adult | 2 | 2018 | 21375 | 0.020 |
Why?
|
| Insecta | 1 | 2004 | 11 | 0.020 |
Why?
|
| Epitopes | 1 | 2004 | 146 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 254 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 100 | 0.010 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2003 | 7 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 37 | 0.010 |
Why?
|
| Skull | 1 | 2003 | 63 | 0.010 |
Why?
|
| Silicones | 1 | 2003 | 32 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2003 | 113 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 351 | 0.010 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 54 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 30 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 25 | 0.010 |
Why?
|
| Lymphokines | 1 | 2001 | 49 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1027 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 7028 | 0.010 |
Why?
|
| Feedback | 1 | 1999 | 90 | 0.010 |
Why?
|
| Crystallins | 1 | 1999 | 9 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2000 | 371 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1996 | 122 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 230 | 0.010 |
Why?
|
| Integrin alpha3beta1 | 1 | 1996 | 2 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 251 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1996 | 21 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 357 | 0.010 |
Why?
|
| Placenta | 1 | 1996 | 101 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1996 | 109 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 562 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1082 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 852 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 1446 | 0.010 |
Why?
|